News Releases

Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic

April 5, 2021

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

March 22, 2021

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock

March 22, 2021

Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy

March 22, 2021

Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology

March 12, 2021

Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

March 8, 2021

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

March 4, 2021

Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference

February 25, 2021

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates

February 16, 2021

Anixa Biosciences to Present at the B. Riley Oncology Investor Conference

January 13, 2021

« Previous
1
2
3
4
5
6
7
8
9
10
...22
Next »

Latest News & Events

Sep 19, 2023

Anixa Biosciences Establishes Cancer Business Advisory Board

Read More...

Aug 31, 2023

Anixa Biosciences to Participate in September Investor Conferences

Read More...

Aug 28, 2023

Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial

Read More...